iron deficiency anaemia
Haematology · 2013–2018
5decisions
3medicines
0carried consumer input
0individual submissions
No submission for this condition has carried consumer input, including the 3 made since the comments facility came into use.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| ferric derisomaltose Treatment of iron deficiency anaemia when treatment with oral iron is ineffective or not tolerated in adult patients. | Jul 2018 | Recommended | none received |
| ferric carboxymaltose Treatment of iron deficiency anaemia (IDA). | Nov 2018 | Recommended | no section in document |
| iron (as sucrose) Iron deficiency anaemia in patients undergoing chronic haemodialysis receiving supplemental erythropoietin therapy. | Nov 2014 | Recommended | none received |
| ferric carboxymaltose Treatment of iron deficiency anaemia where oral iron preparations are not tolerated, ineffective or otherwise inappropriate. | Mar 2013 | Recommended | unclear |
| ferric carboxymaltose Treatment of iron deficiency anaemia in patients who are intolerant or unresponsive to oral iron preparations and for patients who require rapid iron repletion. | Nov 2013 | Recommended | unclear |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 3 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.